“…To analyze IRAK1-expression and IκBα-degradation, we stimulated SV40-immortalized fibroblasts of P1, P2, P3 and P4 as well as of healthy controls with IL-1β (10 ng/ml, R&D Systems), TLR4-agonist lipopolysaccharide (LPS) (10 µg/ml, Sigma-Aldrich) and TNF-α (20 ng/ml, R&D Systems) for 5, 15, 30, 45, 60 and 90 minutes as well as 20, 60, 120 and 240 minutes, respectively. The further steps were performed as described previously using the following antibodies: IκBa (sc-371, Santa Cruz Biotechnology), IRAK1 (sc-7883, Santa Cruz Biotechnology), IRAK-4 (ADI-KAP-ST206-E, Enzo), Glycerinaldehyd-3-phosphat-Dehydrogenase (GAPDH) (sc-25778, Santa Cruz Biotechnology), P38 MAPK (9212S, Cell Signaling), Goat Anti Rabbit IgG (111-035-045, Dianova) [70]. Detailed protocols are available upon request.…”